Yamo Deniz

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis”.

Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.05.019

N/A

6.6DataRank · unranked

233 citations

Amy D. Klion, Pierluigi Paggiaro, Parameswaran Nair, D. Staumont‐Sallé, Amr Radwan +12 more

Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study

The Lancet Respiratory Medicine(2021)10.1016/s2213-2600(21)00322-2

N/A

5.7DataRank · unranked

224 citations

Linda B Ford, Jorge F Maspero, Ian D Pavord, Alberto Papi, Arnaud Bourdin +22 more

Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis

The Lancet Respiratory Medicine(2021)10.1016/s2213-2600(21)00124-7

N/A

4.3DataRank · unranked

143 citations

Sally E. Wenzel, Thomas B. Casale, J. Mark FitzGerald, Megan S. Rice, Nadia Daizadeh +8 more

Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.11.043

N/A

3.0DataRank · unranked

91 citations

Yamo Deniz, Jonathan Corren, Thomas B. Casale, J Mark FitzGerald, Kenji Izuhara +10 more

Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.06.036

N/A

1.2DataRank · unranked

24 citations

J. Mark FitzGerald, Eric D. Bateman, Mario Castro, Ian Pavord, Jorge Máspero +8 more

Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma

Annals of Allergy Asthma & Immunology(2023)10.1016/j.anai.2023.03.014

N/A

0.841DataRank · unranked

23 citations

Leonard B. Bacharier, Wanda Phipatanakul, Lawrence Sher, Christian Domingo, Nikolaos G. Papadopoulos +17 more

Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study

The Journal of Allergy and Clinical Immunology In Practice(2023)10.1016/j.jaip.2023.12.006

N/A

0.697DataRank · unranked

24 citations

Theresa W. Guilbert, Constance H. Katelaris, A. Deschildre, Wanda Phipatanakul, Dongfang Liu +11 more

Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid Dose

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.03.020

N/A

0.659DataRank · unranked

17 citations

Jorge Máspero, Mario Castro, Nicola A. Hanania, Linda B. Ford, David Halpin +10 more

Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate‐to‐severe type 2 asthma

Allergy(2022)10.1111/all.15456

N/A

0.644DataRank · unranked

8 citations

Jonathan Corren, Mario Castro, Christian Domingo, Linda Rogers, Kenneth R. Chapman +9 more

Dupilumab Efficacy and Safety in Children With Moderate to Severe Asthma and High Blood Eosinophils: A Post Hoc Analysis of VOYAGE

The Journal of Allergy and Clinical Immunology In Practice(2024)10.1016/j.jaip.2024.11.014

N/A

0.497DataRank · unranked

12 citations

Eckard Hamelmann, Graham Roberts, Leonard B. Bacharier, Changming Xia, Rebecca Gall +8 more

Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE Study

Journal of Asthma and Allergy(2024)10.2147/jaa.s425101

N/A

0.258DataRank · unranked

3 citations

Kevin R. Murphy, Eckard Hamelmann, Kristie Ross, Atul Gupta, Alessandro Fiocchi +8 more

The burden of systemic corticosteroids in patients with chronic rhinosinusitis with nasal polyps

Allergy and Asthma Proceedings(2025)10.2500/aap.2025.46.250050

N/A

0DataRank · unranked

6 citations

Jayant M. Pinto, Kathleen M. Buchheit, Sietze Reitsma, Andrew Thamboo, Shigeharu Fujieda +6 more

Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation

European Respiratory Journal(2021)10.1183/13993003.03393-2020

N/A

0DataRank · unranked

163 citations

Monica Kraft, Klaus F. Rabe, Yamo Deniz, Paul J. Rowe, Marcella Ruddy +2 more

Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction

Annals of Allergy Asthma & Immunology(2022)10.1016/j.anai.2022.10.018

N/A

0DataRank · unranked

16 citations

Mario Castro, Eric D. Bateman, Ian Pavord, Alberto Papi, J. Mark FitzGerald +15 more

Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation

Journal of Asthma and Allergy(2022)10.2147/jaa.s354013

N/A

0DataRank · unranked

1 citations

Jorge Máspero, David Halpin, David J. Jackson, Reynold A. Panettieri, Mario Castro +9 more

Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases

Journal of Allergy and Clinical Immunology(2023)10.1016/j.jaci.2023.08.017

N/A

0DataRank · unranked

85 citations

Marc E. Rothenberg, Xin Sun, Claus Bachert, David Artis, Raza S. Zaheer +4 more

Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthma

ERJ Open Research(2023)10.1183/23120541.00037-2023

N/A

0DataRank · unranked

4 citations

Constance H. Katelaris, Mario Castro, Jorge Máspero, Marc Humbert, David Halpin +8 more

CLINICAL EFFICACY OF DUPILUMAB TREATMENT DURING WITHDRAWAL OF INHALED CORTICOSTEROIDS/LONG-ACTING BETA AGONISTS

CHEST Journal(2024)10.1016/j.chest.2024.06.2860

N/A

0DataRank · unranked

0 citations

David S. Jackson, KLAUS F RABE, Ian Pavord, J. Christian Virchow, Rohit Katial +9 more

BASELINE CHARACTERISTICS OF PATIENTS ON MEDIUM- VS HIGH-DOSE INHALED CORTICOSTEROIDS IN PATIENTS INITIATING DUPILUMAB IN A REAL-WORLD CLINICAL SETTING: THE RAPID REGISTRY

CHEST Journal(2024)10.1016/j.chest.2024.06.2843

N/A

0DataRank · unranked

0 citations

Andréanne Côté, Arnaud Bourdin, ANJU T PETERS, LEONARD B BACHARIER, Changming Xia +7 more